Montelukast effect in the prevention of respiratory infections
- Conditions
- Common cold.Acute nasopharyngitis [common cold]
- Registration Number
- IRCT2012103111339N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 380
Lack of hyper reactive airway disease;No history of allergic rhinitis;Not taking any medication for a chronic;Absence of chronic heart disease or chronic respiratory disease:
Exclusion criteria
Hyper reactive airway disease (previously treated with bronchodilators in the last three months, Or more than once treatment in the past year or hospitalization for treatment or prophylaxis in recent years with Monteluckast or steroids);History of allergic rhinitis;Taking any medication for a chronic; Chronic heart disease or chronic respiratory disease;Known hypersensitivity to Montelukast;Active URI within one week ago
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of uri attacks. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom checklist.
- Secondary Outcome Measures
Name Time Method Otitis media, Pneumonia, Tonsillitis, Pharyngitis. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom cheklist.;The number of weeks that a child has a fever. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom cheklist.;The use of antibiotics or anti-fever. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom cheklist.;Doctor visits. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom cheklist.;Absences from child care. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom cheklist.;Absent parents. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom cheklist.;Hospitalization. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom cheklist.;Drug reaction. Timepoint: Weekly to 12 weeks. Method of measurement: Call and complete symptom cheklist.